Uncategorized
Expanded indications a possibility for minimally invasive glaucoma surgery
Minimally invasive glaucoma surgery promises to deliver modest IOP lowering for mild and moderate stages of open-angle glaucoma with minimal tissue disruption and complications. Narrow angles and advanced glaucoma stages are considered relative contraindications. Questions also remain about how much IOP reduction is truly attributable to MIGS because of the effect of cataract surgery on IOP that is often performed at the same time.Multiple MIGS devices have been introduced or are currently in development. Ab interno trabeculectomy with the Trabectome (NeoMedix) is the oldest MIGS modality that is FDA approved (Read more...)